...PIK3CA mutations mostly in KRAS wild-type mCRCs resistant to EGFR therapy.,PS detection of low-frequency mutations may i...
...PIK3CA and BRAF were analysed by direct sequencing.,A total of 103 patients were enrolled in the present study. At the p...
...PIK3CA (exons 9 and 20), APC (exon 15) and P53 (exons 4-9), CpG island methylation phenotype status, ploidy, S-phase, LO...
...PIK3CA), RB1 (retinoblastoma 1), STK11 (serine/threonine kinase 11), and tumor protein p53 (TP53) genes. Among the PMPs,...
...PIK3CA, and PTEN in approximately 20% of ccRCCs. Mutations in TSC1, and possibly other genes, may predict for sensitivit...
...PIK3CA gene in 4 of 18 human liposarcoma patients (22%). No PIK3CA mutations were identified in benign lipomas. Western ...
...PIK3CA (n=5). Clinically actionable somatic mutations were detected in 24/35 (69%) patients.,This study demonstrates tha...
...PIK3CA genotyping.,Tumors of 112 pre-registered patients were genotyped for KRAS, BRAF, and PIK3CA. The primary study en...
...PIK3CA, NRAS, MEK1, AKT1, PTEN, and HER2), gene amplifications in 5 genes (EGFR, MET, PIK3CA, FGFR1, and FGFR2), and ALK...
...PIK3CA mutations. The patient has features that cannot be categorized into the present well-known syndromes.
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2026.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
